BBIBP-CorV
E1071417
UNEXPLORED
BBIBP-CorV is an inactivated whole-virus COVID-19 vaccine produced by the Chinese state-owned pharmaceutical company Sinopharm.
All labels observed (1)
| Label | Occurrences |
|---|---|
| BBIBP-CorV canonical | 2 |
How this entity was disambiguated
This entity first appeared as the object of triple T13959216 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: BBIBP-CorV Context triple: [Sinopharm, developed, BBIBP-CorV]
-
A.
BNT162b2
BNT162b2 is an mRNA-based COVID-19 vaccine, co-developed by BioNTech and Pfizer, that became one of the first widely authorized vaccines against SARS-CoV-2.
-
B.
SARS-CoV-2
SARS-CoV-2 is the novel coronavirus responsible for the global outbreak of the respiratory disease COVID-19.
-
C.
Omicron
Omicron is a vowel letter of the Greek alphabet, historically representing a short "o" sound and used today in various scientific and mathematical contexts.
-
D.
Sinovac
Sinovac is a Chinese biopharmaceutical company best known globally for developing the inactivated COVID-19 vaccine CoronaVac.
-
E.
Ad26.COV2.S
Ad26.COV2.S is a single-dose, adenovirus vector-based COVID-19 vaccine developed by Janssen (Johnson & Johnson) to provide protection against SARS-CoV-2 infection.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: BBIBP-CorV Target entity description: BBIBP-CorV is an inactivated whole-virus COVID-19 vaccine produced by the Chinese state-owned pharmaceutical company Sinopharm.
-
A.
BNT162b2
BNT162b2 is an mRNA-based COVID-19 vaccine, co-developed by BioNTech and Pfizer, that became one of the first widely authorized vaccines against SARS-CoV-2.
-
B.
SARS-CoV-2
SARS-CoV-2 is the novel coronavirus responsible for the global outbreak of the respiratory disease COVID-19.
-
C.
Omicron
Omicron is a vowel letter of the Greek alphabet, historically representing a short "o" sound and used today in various scientific and mathematical contexts.
-
D.
Sinovac
Sinovac is a Chinese biopharmaceutical company best known globally for developing the inactivated COVID-19 vaccine CoronaVac.
-
E.
Ad26.COV2.S
Ad26.COV2.S is a single-dose, adenovirus vector-based COVID-19 vaccine developed by Janssen (Johnson & Johnson) to provide protection against SARS-CoV-2 infection.
- F. None of above. chosen
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.